• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈癌筛查项目中新技术的前景。

Prospects for newer technologies in cervical cancer screening programmes.

作者信息

Hailey D M, Lea R

机构信息

Australian Institute of Health and Welfare, Canberra, Australia.

出版信息

J Qual Clin Pract. 1995 Sep;15(3):139-45.

PMID:8528539
Abstract

Because of the limitations of the Pap smear test, much attention has been given to development of technologies to increase the reliability of routine cervical cytology. Newer technologies in this field include automated slide preparation devices, automated slide readers, direct visualization methods and application of flow cytometry and nuclear magnetic resonance. These technologies show promise, but data on their costs, efficacy and effectiveness remain limited. Their introduction in Australia should be linked to local trials, and consideration of their impact on mortality and morbidity and on health care budgets.

摘要

由于巴氏涂片检查存在局限性,人们已将大量注意力投入到提高常规宫颈细胞学检查可靠性的技术研发上。该领域的新技术包括自动玻片制备装置、自动玻片阅读器、直接可视化方法以及流式细胞术和核磁共振的应用。这些技术显示出了前景,但有关其成本、疗效和效果的数据仍然有限。它们在澳大利亚的引入应与当地试验相关联,并考虑其对死亡率、发病率以及医疗保健预算的影响。

相似文献

1
Prospects for newer technologies in cervical cancer screening programmes.宫颈癌筛查项目中新技术的前景。
J Qual Clin Pract. 1995 Sep;15(3):139-45.
2
Clinical and cost implications of new technologies for cervical cancer screening: the impact of test sensitivity.宫颈癌筛查新技术的临床及成本影响:检测敏感性的作用
Am J Manag Care. 2000 Jul;6(7):766-80.
3
[Cervical cancer screening and associated treatment costs in France].[法国宫颈癌筛查及相关治疗费用]
Gynecol Obstet Fertil. 2006 Nov;34(11):1036-42. doi: 10.1016/j.gyobfe.2006.09.005. Epub 2006 Oct 27.
4
Willingness to pay for new Papanicolaou test technologies.对新型巴氏试验技术的支付意愿。
Am J Clin Pathol. 2002 Apr;117(4):524-33. doi: 10.1309/XNUG-XH8V-C1KM-T6GD.
5
Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.香港有组织的与机会性宫颈细胞学筛查的成本效益
J Public Health (Oxf). 2004 Jun;26(2):130-7. doi: 10.1093/pubmed/fdh138.
6
De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam.越南社会主义共和国巴氏涂片细胞学筛查服务的重新建立及其成本效益
Cancer. 2001 Mar 1;91(5):928-39.
7
An alternative cost effectiveness analysis of ThinPrep in the Australian setting.澳大利亚环境下ThinPrep的替代成本效益分析。
Aust N Z J Obstet Gynaecol. 2005 Aug;45(4):289-94. doi: 10.1111/j.1479-828X.2005.00413.x.
8
Advances in cervical screening technology.宫颈筛查技术的进展
Mod Pathol. 2000 Mar;13(3):275-84. doi: 10.1038/modpathol.3880048.
9
[Cost effectiveness of cervical cancer screening strategies in Tunisia].[突尼斯宫颈癌筛查策略的成本效益]
Tunis Med. 2000 Oct;78(10):557-61.
10
Integrating human papillomavirus vaccination in cervical cancer control programmes.将人乳头瘤病毒疫苗接种纳入宫颈癌防控计划。
Public Health Genomics. 2009;12(5-6):352-61. doi: 10.1159/000214925. Epub 2009 Aug 11.

引用本文的文献

1
Digital slide and virtual microscopy based routine and telepathology evaluation of routine gastrointestinal biopsy specimens.基于数字切片和虚拟显微镜的常规胃肠道活检标本的常规及远程病理学评估
J Clin Pathol. 2003 Jun;56(6):433-8. doi: 10.1136/jcp.56.6.433.